Energy And Commerce Committee Chair Upton Is Orphan Drug Advocate
This article was originally published in The Pink Sheet Daily
Executive Summary
Newly-selected House Energy and Commerce Committee Chairman Fred Upton, R-Mich., brings a commitment to orphan drug development to his new role.
You may also be interested in...
"Dormant" Drug Candidates Eligible For Exclusivity Incentives In Draft Bill
Bill floated by the National Health Council would promote development of therapies that have the potential to address an unmet medical need but are viewed by the biopharma industry as unattractive candidates because they have insufficient patent protection.
“Dormant” Drug Candidates Eligible For Exclusivity Incentives In Draft Bill
Biopharmaceutical companies would be offered data exclusivity incentives to develop “dormant” drug candidates for unmet medical needs under draft legislation being floated in the House by the National Health Council patient advocacy organization.
"Dormant" Drug Candidates Eligible For Exclusivity Incentives In Draft Bill
Bill floated by the National Health Council would promote development of therapies that have the potential to address an unmet medical need but are viewed by the biopharma industry as unattractive candidates because they have insufficient patent protection.